Source: International Congress 2016 – Endoscopic lung volume reduction I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ralf Eberhardt (Heidelberg, Germany), Ralf Eberhardt, Dirk-Jan Slebos, Felix J.F. Herth, Kaid Darwiche, Manfred Wagner, Christoph Petermann, Ralf-Harto Hübner, Franz Stanzel, Arschang Valipour. LATE-BREAKING ABSTRACT: A multicenter, prospective, randomized, controlled trial of endobronchial valve therapy vs standard of care in homogeneous emphysema (IMPACT). Eur Respir J 2016; 48: Suppl. 60, 470

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema Source: International Congress 2016 – Advancements in bronchoscopy Year: 2016 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008 Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Telehealth vs. standard care in COPD – a randomized controlled trial Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Outpatient vs. home-based pulmonary rehabilitation in COPD: A randomized controlled trial Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 TargetCOPD: A pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017 An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma inflammation: A randomised, double-blind, placebo-controlled, phase II trial Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020 Year: 2020 Long-term randomized controlled trial to evaluate the efficacy of low expiration with the open glottis in the lateral posture (ELTGOL) in patients with bronchiectasis (BC) Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016